Interleukin-8 increases endothelial permeability independent of neutrophils.

Interleukin-8 (IL-8) has been associated with a variety of hyperinflammatory states and adverse clinical events. Circulating IL-8 levels correlate with the severity of tissue trauma, and excessive elevations of IL-8 are associated with postinjury adult respiratory distress syndrome and multiple organ failure. While IL-8 is a potent neutrophil (PMN) chemoattractant and activator and enhances PMN transendothelial migration, it also acts to inhibit PMN adhesion to stimulated endothelial cells (ECs). We hypothesized that IL-8 could interact directly with ECs to increase permeability independent of PMNs. Human umbilical vein ECs (HUVECs) were cultured on collagen-coated micropore filters, and integrity of the EC monolayer measured by albumin flux across the filter. Cytochalasin D was used as a positive control. IL-8 induced increased permeability at a concentration of 1000 ng/mL. This effect was abrogated by preincubation of HUVECs with a protein synthesis inhibitor (cycloheximide). These data suggest a role for IL-8 in promoting endothelial leak independent of PMNs, via a mechanism involving protein synthesis.

[1]  E. Abraham,et al.  Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients. , 1994, The Journal of trauma.

[2]  M. Ceska,et al.  Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock , 1994, Critical care medicine.

[3]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[4]  W. Shoemaker,et al.  Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury , 1994, Critical care medicine.

[5]  P. Montravers,et al.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome , 1993, Infection and immunity.

[6]  C. Abboud,et al.  Signal Pathway Regulation of Interleukin-8-Induced Actin Polymerization in Neutrophils , 1993 .

[7]  D. Remick,et al.  Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. , 1993, The American journal of pathology.

[8]  D. Phillips,et al.  PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.

[9]  P. Ward,et al.  Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. , 1993, Journal of immunology.

[10]  E. Moore,et al.  Effects of accidental trauma on cytokine and endotoxin production. , 1993, Critical care medicine.

[11]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[12]  J. Tarbell,et al.  Albumin permeability and electrical resistance as means of assessing endothelial monolayer integrity in vitro , 1992 .

[13]  S. Albelda,et al.  Platelet endothelial cell adhesion molecule, PECAM‐1, modulates cell migration , 1992, Journal of cellular physiology.

[14]  F. Luscinskas,et al.  In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. , 1992, Journal of immunology.

[15]  I. Morita,et al.  IL-6 increases endothelial permeability in vitro. , 1992, Endocrinology.

[16]  J. L. Rodriguez,et al.  Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. , 1992, The Journal of trauma.

[17]  M. Gimbrone,et al.  Interleukin‐8 induces changes in human neutrophil actin conformation and distribution: relationship to inhibition of adhesion to cytokine‐activated endothelium , 1992, Journal of leukocyte biology.

[18]  A. Huber,et al.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.

[19]  M. Cybulsky,et al.  Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. , 1991, Journal of immunology.

[20]  B. L. Langille,et al.  Structure and function of the endothelial cytoskeleton. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[21]  J. L. Rodriguez,et al.  Local production of interleukin-8 is associated with nosocomial pneumonia. , 1991, The Journal of trauma.

[22]  W. Seeger,et al.  Adenosine diphosphate-ribosylation of G-actin by botulinum C2 toxin increases endothelial permeability in vitro. , 1991, The Journal of clinical investigation.

[23]  F. Luscinskas,et al.  Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. , 1990, Journal of Immunology.

[24]  Obin,et al.  Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. , 1989, Science.

[25]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[26]  H. Gerlach,et al.  Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins , 1989, The Journal of experimental medicine.

[27]  S. Crooke,et al.  Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. , 1988, The Biochemical journal.

[28]  J I Gallin,et al.  Current concepts: immunology. Neutrophils in human diseases. , 1987, The New England journal of medicine.

[29]  William B. Smith,et al.  Interleukin-8 induces neutrophil transendothelial migration. , 1991, Immunology.

[30]  T. Standiford,et al.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. , 1991, Experimental lung research.